// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1671 Abstracts

Factors associated with extended survival for patients with platinum-resistant ovarian cancer treated with modified vaccinia oncolytic virotherapy.

Madhavi Manyam - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Clinical implication of monitoring PD-L1+ circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC) receiving immunotherapy.

Andrew Daniel Hoffmann - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Pembrolizumab

PD-L1expression on circulating tumor cells and prognosis of breast cancer patients.

Xuefei Wang - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Circulating tumor cell (CTC) PD-L1 and interferon regulatory factor-1 (IRF-1) expression as biomarkers of anti-PD-(L)1 response.

Laura Kennedy - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Interferon

Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients.

Sean Matthew McBride - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

CB-7598

Local experience with ipilimumab and nivolumab in treatment of metastatic melanoma: From world standards to individualized approaches in real clinical practice.

Georgy M. Manikhas - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Ipilimumab

Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.

Michael Joseph Lariviere - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Enzalutamide

Quantifying EpCAM heterogeneity of circulating-tumor-cells (CTCs) from small cell lung cancer (SCLC) patients.

Hadas Sorotsky - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

CT COLONOGRAPHY (CTC) VS OPTICAL COLONOSCOPY (OC) AND A SYSTEMATIC REVIEW AND META ANALYSIS

Madhav Desai - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

NATIONAL PANCREAS FOUNDATIONs (NPF) PATIENT EDUCATION INITIATIVE: ANIMACIONES SOBRE ENFERMEDADES DEL PaNCREAS UNA GUaA ANIMADA PARA PACIENTES SOBRE ENFERMEDADES PANCREaTICAS

Munigala, Satish - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Methadone hydrochloride

LIMITED IMPACT ON CRC DETECTION AND MORTALITY RATES WITH COMPLETE COLONOSCOPY EXAMINATION DESPITE POOR BOWEL PREPARATION

Zillah Cargill - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

CT-Colonography Versus Colonoscopy for Detection of High-Risk Sessile Serrated Polyps

Charlotte Tutein Nolthenius - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Colorectal Cancer

N/A

Colonic Flat Lesions Detection Using 64-MDCT Colonography and a Computer Aided Detection (CAD) System. Radiological-Endoscopical Correlation.

Franco Iafrate - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ulcerative colitis

N/A

High frequencies of PD-1+CD8+ T cells are correlated with PD-L1+ circulating tumor cells (CTC) and have predictive/prognostic value in non-small cell lung cancer (NSCLC) patients

G Kallergi - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Detect: Determing the Effect of Training and Experience on the Accuracy of CT (Computed Tomography) Colonography in Comparison With Optical Colonoscopy in the Detection of Colonic Neoplasia

Yi - Tzu Nancy Fu - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

The Sensitivity of Computed Tomography Colonography in Usual Clinical Practice: Results From the Detect Study (Determing the Effect of Training and Experience on the Accuracy of CTC vs. Colonoscopy)

Yi - Tzu Nancy Fu - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Development of a Simple and Sensitive Quantum Dot Labelled Magnetic Immunoassay Method for Circulating Colorectal Cancer Cell Detection

Pericles C. Pericleous - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

cadmium

An Acute Shower of Circulating Tumour Cells Following Transarterial Embolisation (TAE)

Christina Thirlwell - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How and When to Screen First Degree Relatives of Colorectal Cancer Patients: a Prospective Study

Gabriele Delconte - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY

Pamela Pinzani - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Copyright © 2026. QuantiNova All rights reserved